002821 Asymchem Laboratories(Tianjin)Co.,Ltd.
Closed 07-21 15:00:00
169.50
+6.99
+4.30%
High170.00Low158.50Vol13.05M
Open161.65D1 Closing162.51Amplitude7.08%
Mkt Cap61.19BTradable Cap53.73BTotal Shares361.00M
T/O2.14BT/O Rate4.12%Tradable Shares317.00M
P/B3.27ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Schroders PLC Reduces Stake in Asymchem by 208,000 Shares at HK$132.76 Per Share
Stock News  ·  07-16
Schroders PLC Reduces Stake in Asymchem by 208,000 Shares at HK$132.76 Per Share
Citigroup's Long Position in H-shares of Asymchem Laboratories (tianjin) Decreases to 2.92% on July 10, HKEX Says
Reuters  ·  07-16
Citigroup's Long Position in H-shares of Asymchem Laboratories (tianjin) Decreases to 2.92% on July 10, HKEX Says
Citigroup's Long Position in H-shares of Asymchem Laboratories (tianjin) Decreases to 2.92% on July 10 from 5.09% - HKEX
THOMSON REUTERS  ·  07-16
Citigroup's Long Position in H-shares of Asymchem Laboratories (tianjin) Decreases to 2.92% on July 10 from 5.09% - HKEX
Schroders PLC Reduces Stake in Asymchem by 131,000 Shares at Approximately HK$114 Each
Stock News  ·  07-13
Schroders PLC Reduces Stake in Asymchem by 131,000 Shares at Approximately HK$114 Each
Asymchem Laboratories Receives Additional Stake from JPMorgan
Deep News  ·  07-12
Asymchem Laboratories Receives Additional Stake from JPMorgan
JPMorgan Increases Stake in Asymchem with 143,800 Share Purchase at HK$111.63 Per Share
Stock News  ·  07-10
JPMorgan Increases Stake in Asymchem with 143,800 Share Purchase at HK$111.63 Per Share
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy
MT Newswires Live  ·  07-10
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy
Norges Bank Reduces Stake in Asymchem by 209,100 Shares at HK$112.28 Per Share
Deep News  ·  07-10
Norges Bank Reduces Stake in Asymchem by 209,100 Shares at HK$112.28 Per Share
Asymchem Laboratories Grants 27.8345 Million Incentive Shares Under H-Share Restricted Stock Plan
Stock News  ·  07-08
Asymchem Laboratories Grants 27.8345 Million Incentive Shares Under H-Share Restricted Stock Plan
Asymchem Proposes Adoption of 2026 A-Share Incentive Scheme
Stock News  ·  07-08
Asymchem Proposes Adoption of 2026 A-Share Incentive Scheme
Norges Bank Reduces Stake in Asymchem by 200,000 Shares at Approximately HK$117.93 Each
Stock News  ·  07-08
Norges Bank Reduces Stake in Asymchem by 200,000 Shares at Approximately HK$117.93 Each
Schroders PLC Reduces Stake in Asymchem Laboratories, Selling Shares at HK$108.42 Each
Stock News  ·  07-06
Schroders PLC Reduces Stake in Asymchem Laboratories, Selling Shares at HK$108.42 Each
Norges Bank Reduces Stake in Asymchem by Selling 397,100 Shares at Approximately HK$119.57 Each
Stock News  ·  07-02
Norges Bank Reduces Stake in Asymchem by Selling 397,100 Shares at Approximately HK$119.57 Each
Hong Kong Market Midday Update: Hang Seng Index Edges Up, Chip Stocks Lead Gains
Stock News  ·  06-24
Hong Kong Market Midday Update: Hang Seng Index Edges Up, Chip Stocks Lead Gains
Hong Kong Stock Connect Healthcare ETF Surges Over 5% on Heavy Volume, Led by CXO Sector Rally
Deep News  ·  06-24
Hong Kong Stock Connect Healthcare ETF Surges Over 5% on Heavy Volume, Led by CXO Sector Rally
CRO Sector Stocks Show Robust Gains in Early Trading Session
Deep News  ·  06-24
CRO Sector Stocks Show Robust Gains in Early Trading Session
Asymchem to Repurchase and Cancel 117,500 Restricted A-Shares
Stock News  ·  06-17
Asymchem to Repurchase and Cancel 117,500 Restricted A-Shares
Asymchem Allocates 3.54 Million Yuan for Share Buyback on June 12
Stock News  ·  06-12
Asymchem Allocates 3.54 Million Yuan for Share Buyback on June 12
Asymchem files HKEX next-day disclosure reporting share repurchase cancellation
Reuters  ·  06-12
Asymchem files HKEX next-day disclosure reporting share repurchase cancellation
Asymchem Laboratories Announces Completion of Repurchase and Cancellation of Restricted A Shares Under 2025 Plan
Stock News  ·  06-12
Asymchem Laboratories Announces Completion of Repurchase and Cancellation of Restricted A Shares Under 2025 Plan

Introduction

Company Name.
凯莱英医药集团(天津)股份有限公司
Industry:
医药制造业
Listing Date:
2016-11-18
Main Business:
　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
Issue price:
30.53